BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/12/2021 11:22:24 AM | Browse: 388 | Download: 621
 |
Received |
|
2021-06-15 12:20 |
|
Peer-Review Started |
|
2021-06-15 12:20 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-07-16 05:24 |
|
Revised |
|
2021-07-18 13:23 |
|
Second Decision |
|
2021-08-23 02:40 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-08-23 08:22 |
|
Articles in Press |
|
2021-08-23 08:22 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-09-11 02:36 |
|
Typeset the Manuscript |
|
2021-11-09 07:14 |
|
Publish the Manuscript Online |
|
2021-11-12 11:22 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Clinical Trials Study |
| Article Title |
Induction chemotherapy with albumin-bound paclitaxel plus lobaplatin followed by concurrent radiochemotherapy for locally advanced esophageal cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Mao-Hui Yan, Fang Liu, Bao-Lin Qu, Bo-Ning Cai, Wei Yu and Xiang-Kun Dai |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Fang Liu, MD, Associate Chief Physician, Department of Radiotherapy, The First Medical Center of the Chinese People's Liberation Army (PLA) General Hospital, 28 Fuxing Road, Haidian District, Beijing 100853, China. liufangfsq@163.com |
| Key Words |
Esophageal squamous cell carcinoma; Esophagus cancer; Induction chemotherapy; Concurrent radiochemotherapy; Radiotherapy; Chemotherapy; Albumin-bound paclitaxel; Lobaplatin |
| Core Tip |
To investigate the efficacy and safety of induction chemotherapy with albumin-bound paclitaxel (ABP) plus lobaplatin followed by concurrent radiochemotherapy (RCT) for locally advanced esophageal cancer. A total of 29 patients were included, and 26 of them completed the treatment protocol. Induction chemotherapy with ABP plus lobaplatin followed by concurrent RCT is effective in patients with locally advanced esophageal squamous cell carcinoma, with mild adverse effects. Thus, this protocol is worthy of clinical promotion and application. |
| Publish Date |
2021-11-12 11:22 |
| Citation |
Yan MH, Liu F, Qu BL, Cai BN, Yu W, Dai XK. Induction chemotherapy with albumin-bound paclitaxel plus lobaplatin followed by concurrent radiochemotherapy for locally advanced esophageal cancer. World J Gastrointest Oncol 2021; 13(11): 1781-1790 |
| URL |
https://www.wjgnet.com/1948-5204/full/v13/i11/1781.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v13.i11.1781 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
